Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Randy Dotinga

    News

    SABR could defer systemic therapy in oligoprogressive breast cancer

    Author:
    Randy Dotinga
    Publish date: October 4, 2023

    “We found surprisingly that SABR delayed a change in therapy by 10 months, which is great for patients.”

    • Read More

    News

    Cervical cancer: Vaginal dilation linked to less stenosis after treatment

    Author:
    Randy Dotinga
    Publish date: October 4, 2023

    Sexual intercourse and dilator use may reduce risk of vaginal stenosis following treatment for cervical cancer.

    • Read More

    News

    Elnahal to AVAHO: PACT Act Can Transform, Expand Veteran Care

    Author:
    Randy Dotinga
    Publish date: October 2, 2023

    The US Department of Veterans Affairs (VA) top medical officer told the Association of VA Hematology/Oncology (AVAHO) oncology members that they...

    • Read More

    News

    Transgender patients report stigma, voyeurism in medical care

    Author:
    Randy Dotinga
    Publish date: September 28, 2023

    In focus groups, participants say they fear poor treatment if they’re open and inadequate care if they’re not.

    • Read More

    News

    Florida nurse practitioner convicted in $200 million+ Medicare scheme

    Author:
    Randy Dotinga
    Publish date: September 28, 2023

    The case is part of an ongoing effort by federal prosecutors to target schemes alleged to have defrauded Medicare of billions of dollars in...

    • Read More

    Article

    AVAHO Shines Spotlight on Health Literacy

    Author:
    Randy Dotinga
    Publish date: September 26, 2023
    • Read More

    News

    How targeted drugs can vanquish a virulent leukemia

    Author:
    Randy Dotinga
    Publish date: September 25, 2023

    Targeted therapies have revolutionized the treatment of AML, yet outcomes could be better, and these costly new drugs don’t suit all patients.

    • Read More

    News

    Early glucocorticoid bridging in RA supported by meta-analysis, but concerns remain

    Author:
    Randy Dotinga
    Publish date: September 13, 2023

    Conflicting view: A coauthor of the 2021 American College of Rheumatology guideline says glucocorticoid treatment should be avoided if at all...

    • Read More

    News

    ‘Promising’ new txs for most common adult leukemia

    Author:
    Randy Dotinga
    Publish date: September 8, 2023

    The FDA has already approved these treatments for some other blood cancers, but chronic lymphocytic leukemia (CLL) poses unique challenges.

    • Read More

    News

    Drug price alerts convince 12% of clinicians to change prescriptions

    Author:
    Randy Dotinga
    Publish date: September 6, 2023

    They provide out-of-pocket price estimates specific to individual patients and account for their health plans as opposed to symbols or colors...

    • Read More

    News

    Osteoarthritis cases projected to balloon over next 30 years

    Author:
    Randy Dotinga
    Publish date: September 6, 2023

    In “a major challenge to health systems,” osteoarthritis may affect nearly 1 billion people in 2050.

    • Read More

    News

    Lymphoma specialist to lead MD Anderson’s cancer medicine division

    Author:
    Randy Dotinga
    Publish date: August 22, 2023

    Dr. Christopher Flowers, a prominent African American oncologist with expertise in blood cancer and health disparity research, heads a key...

    • Read More

    News

    PsA biomarkers move researchers closer to predictive test

    Author:
    Randy Dotinga
    Publish date: August 11, 2023

    Researchers have identified 15 genes that may indicate which patients with psoriasis will develop psoriatic arthritis.

    • Read More

    News

    For CLL, BTKi combo bests chemoimmunotherapy

    Author:
    Randy Dotinga
    Publish date: August 9, 2023

    Phase 3 FLAIR trial yields more evidence that younger patients fared better with two-drug combo than with FCR, the once-standard therapy.

    • Read More

    News

    Lawsuit against insurer claims retaliation against docs for out-of-network referrals

    Author:
    Randy Dotinga
    Publish date: July 27, 2023

    The case, filed in 2012, alleges that Aetna harmed patient care by harassing and sacking contract physicians who referred patients to out-of-...

    • Read More

    Pages

    • « first
    • …
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery